AXTAAxalta Coating Systems Ltd.

$32.64+7.8% 1Y

Is the business good?

Good

A genuinely good business: 7 of 9 health tests passed, earnings fully cash-backed (1.4×), and margins widening.

3 good, 1 neutral
Fundamental health (F-score)7 / 9SEC EDGAR · Dec 31, 2025

High fundamental quality. Nine pass/fail tests of year-over-year health from the filings.

Profits arrive as cash1.38×derived · Mar 31, 2026

Operating profit is fully backed by cash. Conversion is improving vs a year ago.

Margin direction, 3 years+4.5 pts

Operating margin has widened over the past few years, the business is getting more profitable per dollar of sales.

Where ROE comes from5% ROA

A balanced mix of margins, efficiency, and leverage. ROE 18% = margin × turnover × leverage.

Unless marked, from derived.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

FCF conversionbetter than 66% of the market
Leverage (Debt/EBITDA)middle of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is AXTA?

Axalta Coating Systems Ltd. earns 11% on the capital it employs against a 9.0% cost of capital, so the business is worth more the bigger it gets.

11%

Return on invested capital · cost of capital 9.0% · 2.2 points above what the capital costs: growth creates value

Operating margin
14%

Operating margin · Specialty Chemicals median 7.4% · 12 months to Q1 2026

Cash conversion
1.38×

Cash conversion · 0.94× a year ago · operating cash flow covers the operating profit after tax

Share count, year on year
−2.2%

Share count, year on year · bought back, each share owns more of the company

Operating margin by fiscal year
YearOperating margin
FY20208.2%
FY202110%
FY20228.7%
FY202311%
FY202413%
FY202514%
Details›
Gross margin12 months to Q1 2026
34%
Operating margin12 months to Q1 2026
14%
Net margin12 months to Q1 2026
7.2%
Free cash flow margin
9.6%
R&D as % of revenue
1.4%
Revenue, trailing twelve months
$5.11B
Free cash flow, trailing twelve months
$488M
Net income, trailing twelve months
$369M
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
11%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.